ALQGC.PA
Quantum Genomics SA
Price:  
0.07 
EUR
Volume:  
127,302.00
France | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALQGC.PA WACC - Weighted Average Cost of Capital

The WACC of Quantum Genomics SA (ALQGC.PA) is 5.7%.

The Cost of Equity of Quantum Genomics SA (ALQGC.PA) is 6.40%.
The Cost of Debt of Quantum Genomics SA (ALQGC.PA) is 5.00%.

Range Selected
Cost of equity 5.00% - 7.80% 6.40%
Tax rate 12.00% - 14.10% 13.05%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.8% - 6.6% 5.7%
WACC

ALQGC.PA WACC calculation

Category Low High
Long-term bond rate 3.0% 3.5%
Equity market risk premium 5.8% 6.8%
Adjusted beta 0.26 0.49
Additional risk adjustments 0.5% 1.0%
Cost of equity 5.00% 7.80%
Tax rate 12.00% 14.10%
Debt/Equity ratio 0.54 0.54
Cost of debt 5.00% 5.00%
After-tax WACC 4.8% 6.6%
Selected WACC 5.7%

ALQGC.PA's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for ALQGC.PA:

cost_of_equity (6.40%) = risk_free_rate (3.25%) + equity_risk_premium (6.30%) * adjusted_beta (0.26) + risk_adjustments (0.75%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.